Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty

被引:16
作者
Borris, Lars C. [1 ]
机构
[1] Arhus Univ Hosp, Dept Orthopaed, Aarhus C, Denmark
关键词
Total hip arthroplasty; Venous thromboembolism; Thromboprophylaxis; Rivaroxaban; Dabigatran etexilate; FACTOR-XA INHIBITOR; DEEP-VEIN THROMBOSIS; MAJOR ORTHOPEDIC-SURGERY; TOTAL KNEE ARTHROPLASTY; DOUBLE-BLIND; REPLACEMENT SURGERY; RANDOMIZED-TRIAL; DOSE-ESCALATION; BAY; 59-7939; ENOXAPARIN;
D O I
10.1007/s00402-009-0930-9
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Extended thromboprophylaxis is vital in patients undergoing total hip arthroplasty (THA) because of the prolonged risk of venous thromboembolism (VTE). Despite evidence that extended prophylaxis can reduce the incidence of symptomatic VTE in this high-risk patient population and the evidence-based guideline recommendations, a large proportion of patients still do not receive an adequate duration of thromboprophylaxis. This is partly due to the limitations of conventional anticoagulants, such as the subcutaneous route of administration or the requirement for routine coagulation monitoring and dose adjustment. New oral anticoagulants (such as the direct thrombin inhibitor dabigatran etexilate and the Factor Xa inhibitor rivaroxaban) could address the current unmet need. Phase III clinical studies in VTE prevention in patients undergoing THA and total knee arthroplasty (TKA) showed that dabigatran etexilate was non-inferior to the EU regimen of enoxaparin, but did not achieve non-inferiority to the US regimen of enoxaparin. In contrast, rivaroxaban demonstrated superiority to both enoxaparin regimens for the prevention of VTE after THA and TKA, without a significant increase in major bleeding rates. Their convenient, once-daily, fixed dosing, with no need for routine coagulation monitoring, could facilitate adherence to evidence-based guideline recommendations of extended thromboprophylaxis after THA.
引用
收藏
页码:583 / 589
页数:7
相关论文
共 50 条
[1]   The pharmacology and management of the vitamin K antagonists [J].
Ansell, J ;
Hirsh, J ;
Poller, L ;
Bussey, H ;
Jacobson, A ;
Hylek, E .
CHEST, 2004, 126 (03) :204S-233S
[2]   Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. [J].
Bauer, KA ;
Eriksson, BI ;
Lassen, MR ;
Turpie, AGG .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (18) :1305-1310
[3]  
Bergqvist D, 1999, Value Health, V2, P288, DOI 10.1046/j.1524-4733.1999.24003.x
[4]  
Choay J, 1981, Ann N Y Acad Sci, V370, P644, DOI 10.1111/j.1749-6632.1981.tb29770.x
[5]   Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study [J].
Cohen, Alexander T. ;
Tapson, Victor F. ;
Bergmann, Jean-Francois ;
Goldhaber, Samuel Z. ;
Kakkar, Ajay K. ;
Deslandes, Bruno ;
Huang, Wei ;
Zayaruzny, Maksim ;
Emery, Leigh ;
Anderson, Frederick A., Jr. .
LANCET, 2008, 371 (9610) :387-394
[6]   Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality [J].
Cohen, Alexander T. ;
Agnelli, Giancarlo ;
Anderson, Frederick A. ;
Arcelus, Juan I. ;
Bergqvist, David ;
Brecht, Josef G. ;
Greer, Ian A. ;
Heit, John A. ;
Hutchinson, Julia L. ;
Kakkar, Ajay K. ;
Mottier, Dominique ;
Oger, Emmanuel ;
Samama, Meyer-Michel ;
Spannagl, Michael .
THROMBOSIS AND HAEMOSTASIS, 2007, 98 (04) :756-764
[7]  
Dahl OE, 2000, HAEMOSTASIS, V30, P101
[8]   Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a metaanalysis of the randomised trials [J].
Eikelboom, JW ;
Quinlan, DJ ;
Douketis, JD .
LANCET, 2001, 358 (9275) :9-15
[9]   Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement:: the RE-MODEL randomized trial [J].
Eriksson, B. I. ;
Dahl, O. E. ;
Rosencher, N. ;
Kurth, A. A. ;
Van Dijk, N. ;
Frostick, S. P. ;
Kalebo, P. ;
Christiansen, A. V. ;
Hantel, S. ;
Hettiarachchi, R. ;
Schnee, J. ;
Buller, H. R. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (11) :2178-2185
[10]   Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty [J].
Eriksson, Bengt I. ;
Borris, Lars C. ;
Friedman, Richard J. ;
Haas, Sylvia ;
Huisman, Menno V. ;
Kakkar, Ajay K. ;
Bandel, Tiemo J. ;
Beckmann, Horst ;
Muehlhofer, Eva ;
Misselwitz, Frank ;
Geerts, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (26) :2765-2775